Adams Wealth Management

Position in GILD — Gilead Sciences, Inc.

CIK 1803084 LOGAN, UT

Position in GILD

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$854,816

+$117,967 QoQ

Shares Held

6,766

+28.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.56%

of 13F equity value

Holder Rank

#1,144

of 2,266 holders

Holding Since

Sep 2020

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Adams Wealth Management holds $3,392,754 across 6 Drug Manufacturers - General names. GILD ranks #1 (25.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc. This page	6,766	$854,816
2	BMY	Bristol Myers Squibb Co	14,065	$810,425
3	ABBV	AbbVie Inc.	3,177	$799,460
4	LLY	ELI LILLY & Co	328	$393,413
5	PFE	Pfizer Inc	11,690	$281,495
6	MRK	Merck & Co., Inc.	1,970	$253,145

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$854,816	6,766	+28.0%	Shares	Other	2026-08-10
2026-03-31	$736,849	5,287	+6.3%	Shares	Other	2026-05-12
2025-12-31	$610,263	4,972	-5.7%	Shares	Sole	2026-02-18
2025-09-30	$585,303	5,273	-10.5%	Shares	Sole	2025-11-14
2025-06-30	$653,356	5,893	+593.3%	Shares	Sole	2025-09-25
2020-09-30	$53,711	850	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.